A detailed history of Yarbrough Capital, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Yarbrough Capital, LLC holds 4,267 shares of ZTS stock, worth $755,088. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,267
Previous 4,267 -0.0%
Holding current value
$755,088
Previous $739,000 12.72%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 12, 2023

BUY
$160.94 - $186.23 $313,028 - $362,217
1,945 Added 83.76%
4,267 $734,000
Q2 2022

Jul 08, 2022

SELL
$155.97 - $200.09 $427,825 - $548,846
-2,743 Reduced 54.16%
2,322 $399,000
Q1 2022

Apr 14, 2022

BUY
$181.39 - $234.03 $111,373 - $143,694
614 Added 13.79%
5,065 $955,000
Q4 2021

Feb 01, 2022

BUY
$193.69 - $247.03 $862,114 - $1.1 Million
4,451 New
4,451 $1.09 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Yarbrough Capital, LLC Portfolio

Follow Yarbrough Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yarbrough Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yarbrough Capital, LLC with notifications on news.